300406 Stock Overview
Offers in-vitro diagnostics products and services in the People’s Republic of China and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 5/6 |
| Future Growth | 3/6 |
| Past Performance | 3/6 |
| Financial Health | 5/6 |
| Dividends | 4/6 |
Beijing Strong Biotechnologies,Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CN¥14.16 |
| 52 Week High | CN¥21.78 |
| 52 Week Low | CN¥11.01 |
| Beta | 0.35 |
| 11 Month Change | -1.05% |
| 3 Month Change | 11.94% |
| 1 Year Change | -27.31% |
| 33 Year Change | -10.38% |
| 5 Year Change | -19.77% |
| Change since IPO | -39.10% |
Recent News & Updates
Recent updates
Shareholder Returns
| 300406 | CN Biotechs | CN Market | |
|---|---|---|---|
| 7D | -5.4% | -1.9% | -2.8% |
| 1Y | -27.3% | -21.0% | 2.0% |
Return vs Industry: 300406 underperformed the CN Biotechs industry which returned -19.8% over the past year.
Return vs Market: 300406 underperformed the CN Market which returned 3.2% over the past year.
Price Volatility
| 300406 volatility | |
|---|---|
| 300406 Average Weekly Movement | 7.8% |
| Biotechs Industry Average Movement | 9.0% |
| Market Average Movement | 8.4% |
| 10% most volatile stocks in CN Market | 12.7% |
| 10% least volatile stocks in CN Market | 5.6% |
Stable Share Price: 300406 has not had significant price volatility in the past 3 months compared to the CN market.
Volatility Over Time: 300406's weekly volatility (8%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2001 | 1,094 | Xi Liu | www.bsbe.com.cn |
Beijing Strong Biotechnologies,Inc. offers in-vitro diagnostics products and services in the People’s Republic of China and internationally. The company provides clinical biochemistry products, such as reagents and automatic biochemistry analyzers; coagulation products, including reagents and automated coagulation analyzers; pathology and liquid buiopsy and serology products comprising blood type test cards and automated blood grouping analyzers.
Beijing Strong Biotechnologies,Inc. Fundamentals Summary
| 300406 fundamental statistics | |
|---|---|
| Market cap | CN¥8.26b |
| Earnings (TTM) | CN¥525.81m |
| Revenue (TTM) | CN¥1.75b |
15.7x
P/E Ratio4.7x
P/S RatioIs 300406 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 300406 income statement (TTM) | |
|---|---|
| Revenue | CN¥1.75b |
| Cost of Revenue | CN¥418.61m |
| Gross Profit | CN¥1.33b |
| Other Expenses | CN¥800.92m |
| Earnings | CN¥525.81m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.90 |
| Gross Margin | 76.02% |
| Net Profit Margin | 30.13% |
| Debt/Equity Ratio | 29.4% |
How did 300406 perform over the long term?
See historical performance and comparison